Subscribe today!
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
All Research Areas
News
Magazine
Multimedia
Multimedia
Webinars
eBooks
Podcasts
Infographics
Videos
Milestones - Articles
Explainers - Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
All Multimedia
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
All Research Areas
News
Magazine
Multimedia
Multimedia
Webinars
eBooks
Podcasts
Infographics
Videos
Milestones - Articles
Explainers - Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
All Multimedia
Subscribe!
Subscribe Today!
Mel J. Yeates
This person does not yet have a bio.
Articles by Mel J. Yeates
| 2 min read
by
Mel J. Yeates
Kiromic completes GMP manufacturing facility
Kiromic’s GMP manufacturing facility in Houston will support the company’s first-in-human allogenic CAR-T trial
News
| 2 min read
by
Mel J. Yeates
Thermo Fisher Scientific buys Henogen from Novasep
Acquisition will expand Thermo Fisher’s global capacity for cell and gene therapies
News
| 3 min read
by
Mel J. Yeates
A new pathway against glioblastoma
Researchers have linked a cellular transport pathway to glioblastoma multiforme
News
| 2 min read
by
Mel J. Yeates
Moderna COVID-19 vaccine gains nod from UK
The MHRA has granted temporary authorization for the use of the company’s mRNA-based vaccine
News
| 2 min read
by
Mel J. Yeates
Everlywell signs distribution agreement with Ginkgo Bioworks
Everlywell will distribute FDA-authorized rapid antigen testing for organizations and public health agencies
News
| 2 min read
by
Mel J. Yeates
HIV vaccine candidate VIR1111 enters Phase 1
Vir Biotechnology initiates Phase 1 trial to evaluate a novel HIV vaccine platform
News
| 3 min read
by
Mel J. Yeates
Ketamine infusions prove promising in PTSD
Repeated infusions reduce severity of symptoms in chronic post-traumatic stress disorder
News
| 4 min read
by
Mel J. Yeates
Choosing CRISPR in the fight against SARS-CoV-2
Study demonstrates how changes in human genes can reduce SARS-CoV-2 infection
Articles
| 3 min read
by
Mel J. Yeates
Functional MRI: The next tool for mental health?
Researchers develop an algorithm for predicting medication response in mental health patients
Articles
| 4 min read
by
Mel J. Yeates
Tracing cancer with tattoo ink
USC researchers say tattoo inks and food dyes could help improve cancer detection
Articles
| 2 min read
by
Mel J. Yeates
Atossa shares Phase 1 results for AT-301
Preliminary results show safety and tolerability of AT-301 nasal spray for COVID-19
Articles
| 4 min read
by
Mel J. Yeates
Putting RWD and NHD up against placebo
Results from cTAP indicate both could augment or replace placebo controls in DMD clinical trials
Articles
Page 4 of 48 - 574 Total Items
1
2
3
4
5
6
7
8
9
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe
Sponsored
A new era of therapeutic antibodies
Explore the scientific advances driving more specific, potent, and adaptable antibody-based therapies.
Ebooks
Rapid sterility testing for advanced therapy manufacturing
Explore how digital PCR is reshaping sterility testing to support faster, more reliable release of advanced therapy medicinal products.
Articles
Milestone: The parallel evolution of organoids and high-content imaging
Explore how breakthroughs in fast confocal imaging and 3D cell culture converged to transform the study of complex human biology
in vitro.
Milestones
Latest Issue
Volume 21 • Issue 4 • December 2025
December 2025
December 2025 Issue
Explore this issue